Patents by Inventor Enrique CARRAZANA

Enrique CARRAZANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230084521
    Abstract: The present disclosure pertains to the use of propofol prodrugs, pharmaceutically acceptable salts of propofol prodrugs, or mixtures thereof, to treat migraine.
    Type: Application
    Filed: September 9, 2022
    Publication date: March 16, 2023
    Inventors: Michael A. Rogawski, Enrique Carrazana, Edward Brendan Magrab, Steven L. Krill, Allen H. Heller
  • Patent number: 11491144
    Abstract: The invention provides a method of treating FX syndrome and FX premutation by administering an effective amount of a ?-opioid receptor antagonist to an individual having FX syndrome or FX premutation.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: November 8, 2022
    Assignees: The Florida State University Research Foundation, Incorporated, Avekshan LLC
    Inventors: Pradeep G. Bhide, Deirdre McCarthy, Enrique Carrazana, John W. Cran
  • Publication number: 20220105111
    Abstract: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, to treat migraine.
    Type: Application
    Filed: March 26, 2020
    Publication date: April 7, 2022
    Inventors: Michael A. Rogawski, Enrique Carrazana, Edward Brendan Magrab, Steven L. Krill, Allen H. Heller
  • Publication number: 20220105050
    Abstract: The present disclosure pertains to the use of propofol prodrugs, pharmaceutically acceptable salts of propofol prodrugs, or mixtures thereof, to treat migraine.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 7, 2022
    Inventors: Michael A. Rogawski, Enrique Carrazana, Edward Brendan Magrab, Steven L. Krill, Allen Heller
  • Publication number: 20190298703
    Abstract: The invention provides a method of treating FX syndrome and FX premutation by administering an effective amount of a ?-opioid receptor antagonist to an individual having FX syndrome or FX premutation.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 3, 2019
    Inventors: Pradeep G. BHIDE, Deirdre MCCARTHY, Enrique CARRAZANA, John W. CRAN